Analystreport

Myovant Sciences Ltd (NASDAQ: MYOV) had its "buy" rating re-affirmed by analysts at Robert W. Baird. They now have a $20.00 price target on the stock.

Myovant Sciences Ltd. Common Shares  (MYOV) 
Last myovant sciences ltd. common shares earnings: 2/10 08:30 am Check Earnings Report
US:NYSE Investor Relations: investors.myovant.com